UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059912
Receipt number R000067761
Scientific Title Association between preoperative phase angle and 1-year mortality in patients undergoing transcatheter aortic valve implantation: a prospective observational study
Date of disclosure of the study information 2025/11/28
Last modified on 2025/11/28 08:01:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on body composition and prognosis in patients undergoing catheter treatment for aortic valve stenosis

Acronym

A study on cardiac treatment and body composition

Scientific Title

Association between preoperative phase angle and 1-year mortality in patients undergoing transcatheter aortic valve implantation: a prospective observational study

Scientific Title:Acronym

Phase angle and prognosis in TAVI patients

Region

Japan


Condition

Condition

aortic valve stenosis

Classification by specialty

Cardiology Anesthesiology Cardiovascular surgery
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to clarify the association between preoperative phase angle (PhA) and 1-year all-cause mortality in patients undergoing TAVI, and to evaluate whether PhA remains an independent prognostic factor after adjustment for established risk factors.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is all-cause mortality within 1 year after TAVI. Mortality will be ascertained from hospital electronic medical records, outpatient clinic records, and, if necessary, telephone follow-up. The time point of evaluation is defined as one year after the date of the TAVI procedure.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled to undergo transcatheter aortic valve implantation (TAVI) at our institution

Patients capable of providing written informed consent

Key exclusion criteria

Patients with pacemaker or implantable cardioverter-defibrillator (ICD), in whom bioelectrical impedance analysis (BIA) is contraindicated

Emergency cases

Patients on chronic dialysis

Valve-in-valve cases (redo transcatheter valve implantation within a previously implanted bioprosthetic valve)

Patients undergoing TAVI via non-transfemoral approaches

Patients converted to open surgical aortic valve replacement

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Fujiwara
Middle name
Last name Atsushi

Organization

Osaka Medical and Pharmaceutical University

Division name

Department of Anesthesiology

Zip code

569-8686

Address

2-7 Daigaku-machi, Takatsuki, Osaka, Japan

TEL

072-683-1221

Email

atsushi.fujiwara@ompu.ac.jp


Public contact

Name of contact person

1st name Mitsui
Middle name
Last name Hiroaki

Organization

Osaka Medical and Pharmaceutical University

Division name

Department of Anesthesiology

Zip code

569-8686

Address

2-7 Daigaku-machi, Takatsuki, Osaka, Japan

TEL

072-683-1221

Homepage URL


Email

hiroaki.mitsui@ompu.ac.jp


Sponsor or person

Institute

Department of Anesthesiology, Osaka Medical and Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, Osaka Medical and Pharmaceutical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Anesthesiology, Osaka Medical and Pharmaceutical University

Address

2-7 Daigaku-machi, Takatsuki, Osaka, Japan

Tel

072-683-1221

Email

hiroaki.mitsui@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 10 Month 23 Day

Date of IRB

2025 Year 10 Month 23 Day

Anticipated trial start date

2025 Year 11 Month 12 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Preoperative phase angle (PhA) will be measured using bioelectrical impedance analysis (BIA). Clinical data including laboratory findings (albumin, hemoglobin, creatinine, BNP, LVEF, etc.) and comorbidities will be collected from electronic medical records. Patients will be followed for 1 year after TAVI by reviewing hospital records, outpatient records, or telephone contact to ascertain all-cause mortality (primary outcome).


Management information

Registered date

2025 Year 11 Month 28 Day

Last modified on

2025 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067761